Cancer Management and Research
Volume 11, 2019 - Issue
Open access
77
Views
8
CrossRef citations to date
0
Altmetric
Original Research
MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers
Bei Pan1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Bangshun He1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Xueni Xu1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;2 School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China
, Xiangxiang Liu1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Tao Xu1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Mu Xu1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Xiaoxiang Chen1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;2 School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China
, Kaixuan Zeng1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;2 School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China
, Kang Lin3 Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Xiuxiu Hu1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;2 School of Medicine, Southeast University, Nanjing 210009, People’s Republic of China
, Li Sun4 Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, People’s Republic of China
, Yuqin Pan1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
, Huiling Sun1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China
& Shukui Wang1 General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;3 Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China;5 Jiangsu Collaborative Innovation Center on Cancer Personalized Medicine, Nanjing Medical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
show all
Pages 5437-5457
|
Published online: 13 Jun 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.